focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades

Tue, 23rd Nov 2021 10:27

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday afternoon:

----------

FTSE 100

----------

LBBW RAISES SHELL PRICE TARGET TO 1,800 (1,600) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS RIO TINTO PRICE TARGET TO 5,200 (6,000) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ANGLO AMERICAN PRICE TARGET TO 3,400 (3,600) PENCE - 'BUY'

----------

BERENBERG RAISES HALMA PRICE TARGET TO 2,980 (2,575) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES DIAGEO PRICE TARGET TO 4,650 (4,200) PENCE - 'BUY'

----------

BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,630 (1,540) PENCE - 'BUY'

----------

BERENBERG RAISES AUTO TRADER GROUP PRICE TARGET TO 745 (650) PENCE - 'HOLD'

----------

BERENBERG RAISES BARRATT DEVELOPMENTS TO 'BUY' (HOLD) - PRICE TARGET 810 (850) PENCE

----------

JPMORGAN RESUMES MEGGITT WITH 'NEUTRAL' - TARGET 800 PENCE

----------

BRYAN GARNIER CUTS ASTRAZENECA TO 'BUY' (CONVICTION BUY) - PRICE TARGET 10,500 PENCE

----------

KEPLER CHEUVREUX CUTS ASTRAZENECA PRICE TARGET TO 9,500 (9,800) PENCE - 'BUY'

----------

FTSE 250

----------

LIBERUM RAISES BIG YELLOW GROUP TO 'BUY' (HOLD) - PRICE TARGET 1,720 (1,550) PENCE

----------

JEFFERIES CUTS BIG YELLOW GROUP TO 'HOLD' (BUY) - PRICE TARGET 1,686 (1,550) PENCE

----------

BERENBERG CUTS HOCHSCHILD MINING TO 'HOLD' (BUY) - PRICE TARGET 130 (200) PENCE

----------

PEEL HUNT CUTS HOCHSCHILD MINING TO 'HOLD' ('BUY') - TARGET 112 (250) PENCE

----------

BOFA CUTS HOCHSCHILD MINING TO 'UNDERPERFORM' (BUY) - TARGET 90 (280) PENCE

----------

BERENBERG RAISES CREST NICHOLSON TO 'BUY' (HOLD) - PRICE TARGET 410 (450) PENCE

----------

BARCLAYS RAISES DIPLOMA PRICE TARGET TO 3,290 (3,040) PENCE - 'OVERWEIGHT'

----------

RBC RAISES DIPLOMA PRICE TARGET TO 2,550 (2,250) PENCE - 'UNDERPERFORM'

----------

JPMORGAN RAISES DIPLOMA PRICE TARGET TO 2,950 (2,730) PENCE - 'NEUTRAL'

----------

SOCGEN CUTS HAMMERSON TO 'SELL' (HOLD) - PRICE TARGET 2,750 (3,800) PENCE

----------

GOLDMAN SACHS CUTS GREAT PORTLAND ESTATES PRICE TARGET TO 860 (893) PENCE - 'BUY'

----------

GOLDMAN CUTS WH SMITH PRICE TARGET TO 2,000 (2,100) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.